The aim of this study was to characterize the acute inflammatory phase of the disease upon infection and evaluate whether exogenous human recombinant HspB5 could be used to protect cochlear neurosensory cells in an infant rat model of S. pneumoniae-induced bacterial meningitis. Here, CRYAB is linked to infection.